Not Yet Recruiting NA INTERVENTIONAL 2-arm
NCT07236827
A Comparison of Endoscopic Synchronous Injection and Submucosal Dissection(ESISD) and Conventional Endoscopic Submucosal Dissection(CESD) for Granular Mixed Nodular Laterally Spreading Tumor in the Rectum (LST-G-M) (ESISD vs CESD)
Sponsor: Taihe Hospital
Conditions
Endoscopic Resection Rectal Tumor
Interventions
Conventional Endoscopic Submucosal Dissection(ESD) Endoscopic Synchronous Injection and Submucosal Dissection(ESISD)
Updated 1 time since 2025 Last updated: Nov 14, 2025 Started: Dec 1, 2025 Primary completion: Dec 1, 2026 Completion: Dec 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07236827, this NA trial focuses on Endoscopic Resection and Rectal Tumor and remains actively recruiting participants. Sponsored by Taihe Hospital, it has been updated 1 time since 2025, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
1 version recorded Not Yet Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Taihe Hospital
Data source: Taihe Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.